protected-pilot · 90 days
90-Day Enterprise Atlas Pilot
Design the tenant, governance, interoperability, audit, runtime safety, and value model required for a controlled enterprise deployment.
Target buyer
Health systems, payers, governments, and enterprise operators preparing controlled deployment
Recommended protected-pilot range: $400k-$1.25M; $1.25M-$2M+ for multi-site, sandbox-planning, or buyer-specific protected diligence scope
Request this pilotIncluded product proof
Inspectable demos ground the pilot in real product surfaces.
Atlas Interoperability Readiness Demo
SCRIMED Atlas · Interoperability Agent
Demonstrate standards-aware synthetic conformance evidence with exact live-use blockers retained.AgentOS Governance Evaluation Demo
SCRIMED AgentOS · Planner, Router, Specialist Agents, and TrustQA
Demonstrate how a synthetic enterprise workflow packet becomes a governed multi-agent plan and Atlas Trust Card.CarePath Access Operations Demo
CarePath AI · Scheduling Agent
Demonstrate how a fragmented high-risk follow-up queue becomes a reviewable operational routing packet.Identity and access decisions approved
Measured against a buyer-approved operational baseline and governance boundary.
Connector scope and conformance plan approved
Measured against a buyer-approved operational baseline and governance boundary.
Runtime safety and audit owners assigned
Measured against a buyer-approved operational baseline and governance boundary.
Annual license decision supported by measured value
Measured against a buyer-approved operational baseline and governance boundary.
Activation requirements
The pilot starts only when buyer inputs and governance gates are explicit.
Required context
Business, workflow, and operating information needed to produce decision-grade evidence.
- Executive steering sponsor
- Security, privacy, compliance, and legal participation
- Workflow and integration owners
- Approved baseline and value methodology
Required controls
Conditions that keep the engagement auditable, human-reviewed, and healthcare-safe.
- BAA and data-boundary decisions defined before live data
- Tenant identity and roles approved
- Durable audit and incident response approved
- Human-review procedures approved
Not included
Capabilities that remain denied or require a separate protected-production approval path.
- No live clinical execution until every required control is approved
- No unsupported clinical or reimbursement claims
- No connector activation without partner acceptance
- No autonomous diagnosis or treatment
Share the proposed scope, commercial model, metrics, inputs, gates, and exclusions.
StartRequest this pilotOpen the governed enterprise intake with the closest matching service offer selected.
ProofInspect all demosReview the product evidence that can be packaged into the engagement.
CommercialReview pricing strategyInspect expansion paths from evaluation into protected pilot and enterprise license.
AcceleratorReview market alignmentInspect benchmark context, price bands, and demo-to-pilot routing.